Ontology highlight
ABSTRACT: Rationale
Clinical trials and human laboratory studies have established that varenicline can reduce rates of alcohol use among heavy drinkers. Less is known about the mechanisms by which varenicline has this effect on drinking behavior. Reactivity to alcohol cues is often cited as the primary cause of relapse among those being treated for alcohol use disorder, and several front-line treatments for alcohol use disorder work, at least in part, by minimizing cue-induced alcohol craving.Objective
The current double-blind, placebo-controlled human laboratory study tested the effects of varenicline on alcohol cue reactivity in a group of heavy-drinking adult smokers and nonsmokers.Methods
As part of a larger series of sequential human laboratory experiments testing the ef
SUBMITTER: Roberts W
PROVIDER: S-EPMC5709183 | biostudies-literature | 2017 Sep
REPOSITORIES: biostudies-literature